Research map: Sodium‐Glucose Cotransporter 2 Inhibitors and Cancer Risk in Patients With Type 2 Diabetes Mellitus: An Active Comparator, New‐User Cohort Study

Back to the article

Papers in this map

  1. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries · Freddie Bray · 2024 · 26051 citations · Cited by this paper
  2. Helicobacter pylori Infection and the Risk of Biliary Tract and Pancreatic Cancers: Subsite‐Specific Associations in a Japanese Population · 2026 · Related
  3. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 · Kanyin Liane Ong · 2023 · 4687 citations · Cited by this paper
  4. Unraveling the Plasma Extracellular Vesicles Proteome: Predictors of Resistance in Immunotherapy of Advanced Melanoma · 2026 · Related
  5. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies · Peter C. Austin · 2015 · 4545 citations · Cited by this paper
  6. The Optimal Lung Cancer Ct Screening Strategy: A Cost‐Effectiveness Study Incorporating Nelson Evidence, Evolving Cost of Treatment and Smoking Cessation Interventions · 2026 · Related
  7. Type 2 diabetes · Sudesna Chatterjee · 2017 · 2538 citations · Cited by this paper
  8. The Circulating Cholangiocarcinoma Protein Biomarkers CRP and MASP2 Also Predict Gallbladder Cancer Risk · 2026 · Related
  9. Cancer incidence and mortality in China, 2022 · Bingfeng Han · 2024 · 2241 citations · Cited by this paper
  10. Obesity‐Driven Early‐Onset Colorectal Cancer: Mechanistic Insights and Emerging Clinical Implications · 2026 · Related
  11. Immortal Time Bias in Pharmacoepidemiology · Samy Suissa · 2007 · 1793 citations · Cited by this paper
  12. Changing the History of Science—An Editorial Perspective on Critical Developments in Current Citation Practice, “Forgetting” the Pioneers of Scientific Discoveries · 2026 · Related
  13. Evaluating Medication Effects Outside of Clinical Trials: New-User Designs · Wayne A. Ray · 2003 · 1656 citations · Cited by this paper
  14. Targeted Therapy and Oral Chemotherapy as Maintenance Treatment in Pediatric Very‐High‐Risk and High‐Risk Rhabdomyosarcoma: A Retrospective Study of Efficacy and Safety · 2026 · Related
  15. Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050 · Simiao Chen · 2023 · 896 citations · Cited by this paper
  16. Neoadjuvant Chemotherapy Versus Upfront Surgery for cT2N1 or cT3a ‐ bN0 ‐1 Middle‐High Rectal Cancer · 2026 · Related
  17. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies · Konstantinos K. Tsilidis · 2015 · 883 citations · Cited by this paper
  18. HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer · 2026 · Related
  19. The Active Comparator, New User Study Design in Pharmacoepidemiology: Historical Foundations and Contemporary Application · Jennifer Leigh Lund · 2015 · 728 citations · Cited by this paper
  20. Future Trends in Cancer Prevention and Interception in Cancer Predisposition Syndromes: Leveraging Insights From High‐Risk Populations · 2026 · Related
  21. Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation · Lotte Bjerre Knudsen · 2010 · 663 citations · Cited by this paper
  22. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024 · Nuha A. ElSayed · 2023 · 662 citations · Cited by this paper
  23. Metformin and the Risk of Cancer · Samy Suissa · 2012 · 535 citations · Cited by this paper
  24. Review: Diabetes, Obesity, and Cancer—Pathophysiology and Clinical Implications · Iliana Carolina Lega · 2019 · 367 citations · Cited by this paper
  25. Global burden of cancer and associated risk factors in 204 countries and territories, 1980–2021: a systematic analysis for the GBD 2021 · Zeng‐Hong Wu · 2024 · 360 citations · Cited by this paper
  26. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer · Julien Bezin · 2022 · 313 citations · Cited by this paper
  27. Transparent Reporting of Observational Studies Emulating a Target Trial—The TARGET Statement · Aidan Gregory Cashin · 2025 · 235 citations · Cited by this paper
  28. SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials · Huilin Tang · 2017 · 212 citations · Cited by this paper
  29. Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists · Agata Winiarska · 2021 · 195 citations · Cited by this paper
  30. Glucagon‐like peptide‐1 receptor agonists improve biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomised controlled trials · Jonathan James Hyett Bray · 2021 · 194 citations · Cited by this paper
  31. Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma · Claudio Scafoglio · 2018 · 180 citations · Cited by this paper
  32. Target Trial Emulation to Improve Causal Inference from Observational Data: What, Why, and How? · Edouard L. Fu · 2023 · 180 citations · Cited by this paper
  33. Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records · Yan Xie · 2023 · 104 citations · Cited by this paper
  34. Sodium‐glucose co‐transporter‐2 (SGLT‐2) inhibitors and cancer: A meta‐analysis of randomized controlled trials · Ilaria Dicembrini · 2019 · 85 citations · Cited by this paper
  35. Incretin Receptors in Non-Neoplastic and Neoplastic Thyroid C Cells in Rodents and Humans: Relevance for Incretin-Based Diabetes Therapy · Beatrice Waser · 2011 · 81 citations · Cited by this paper
  36. Effects of novel SGLT2 inhibitors on cancer incidence in hyperglycemic patients: a meta-analysis of randomized clinical trials · Rosaria Benedetti · 2021 · 77 citations · Cited by this paper
  37. SGLT2 inhibition restrains thyroid cancer growth via G1/S phase transition arrest and apoptosis mediated by DNA damage response signaling pathways · Yan Wang · 2022 · 70 citations · Cited by this paper
  38. Genitourinary Tract Infections in Patients Taking SGLT2 Inhibitors · Veraprapas Kittipibul · 2024 · 67 citations · Cited by this paper
  39. Risk of thyroid cancer associated with glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: A population‐based cohort study · Sungho Bea · 2023 · 63 citations · Cited by this paper

Source: OpenAlex (CC0)